CSP
BSX icon

Cary Street Partners’s Boston Scientific BSX Stock Holding History

Cary Street Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
25,092
+3,597
+17% +$195K 0.02% 486
2026
Q1 		$1.35M Buy
21,495
+581
+3% +$46.5K 0.03% 391
2025
Q4 		$1.99M Buy
20,914
+2,599
+14% +$255K 0.05% 328
2025
Q3 		$1.79M Sell
18,315
-403
-2% -$41.7K 0.05% 337
2025
Q2 		$2.01M Buy
18,718
+2,332
+14% +$236K 0.06% 305
2025
Q1 		$1.65M Sell
16,386
-366
-2% -$36.9K 0.05% 313
2024
Q4 		$1.5M Buy
+16,752
New +$1.47M 0.05% 319

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Cary Street Partners's BSX Position: Q2 2026 in Review

Cary Street Partners increased its Boston Scientific (BSX) stake by 17% in Q2 2026, buying an estimated $195K and bringing the position to 25,092 shares worth $1.07M. The position accounts for 0.02% of the portfolio, ranked #486.

Cary Street Partners first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.01M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cary Street Partners held 25,092 shares of Boston Scientific worth $1.07M as of Q2 2026.
  • Cary Street Partners bought 3,597 Boston Scientific shares in Q2 2026, an estimated $195K.
  • Boston Scientific made up 0.02% of Cary Street Partners's portfolio in Q2 2026, its #486 holding.
  • Cary Street Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Boston Scientific position peaked at $2.01M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.